ZelicksonB,MatsumaraK,KistD,EpsteinEH,BartBJ, 1995.Bart's syndrome: Ultrastructure and genetic linkage,Arch Dermatol 131 663 -8
MühleC,JiangQJ,CharlesworthA,Bruckner-TudermanL,MeneguzziG,SchneiderH. Novel, 2005.and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: Molecular basis and clinical course of Herlitz disease,Hum Genet 116 33 -42
NakanoA,LestringantGG,PapernaT,BergmanR,GershoniR,FrossardP, 2002.Junctional epidermolysis bullosa in the Middle East: Clinical and genetic studies in a series of consanguineous families,J Am Acad Dermatol 46 510 -6
LeeKE,KoJ,Tran LeCG,ShinTJ,HyunHK,LeeSH, 2015.Novel LAMB3 mutations cause non-syndromic amelogenesis imperfecta with variable expressivity,Clin Genet 87 90 -2
YangCS,KroshinskyD,CummingsBM, 2014.Neonatal junctional epidermolysis bullosa: Treatment conundrums and ethical decision making,Am J Clin Dermatol 15 445 -50
InamadarAC,PalitA,RagunathaS., 2014.Textbook of pediatric dermatology,JAYPEE - The health sciences publishers. New Delhi - India. 2nd edition 340 -
PasmooijAM,NijenhuisM,BranderR,JonkmanMF, 2012.Natural gene therapy may occur in all patients with generalized nonHerlitz junctional epidermolysis bullosa with COL17A1 mutations,J Invest Dermatol 132 1374 -83
ShaiqPA,KlauseggerA,LatifA,BauerJ,QamarR,RajaGK, 2012.Missense mutation in LAMA3 associated with Herlitz junctional epidermolysis bullosa in a Pakistani family,Pak J Zool 44 1697 -1702
McGrathJA,KivirikkoS,CiattiS,MossC,DunnillMGS,EadyRA, 1995.A homozygous nonsense mutation in the alpha-3 chain gene of laminin 5 (LAMA3) in Herlitz junctional epidermolysis bullosa: Prenatal exclusion in a fetus at risk,Genomics 29 282 -4
McGrathJA,KivirikkoS,CiattiS,MossC,ChristianoAM,UittoJ., 1996.A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz junctional epidermolysis bullosa in patients of Pakistani ancestry: Evidence for a founder effect,J Invest Dermatol 106 781 -4